Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00227929 · ClinicalTrials.gov registry record · NA

Culturally Sensitive Collaborative Treatment for Depressed Chinese Americans

A NA study of Depression, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT00227929: Completed NA study of Depression, sponsored by Massachusetts General Hospital.

NCT00227929 is a NA study of Depression that has completed, run by Massachusetts General Hospital. The registered enrollment target is 120 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00227929, a NA study of Depression, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of culturally sensitive treatment versus regular care in treating depressed Chinese Americans.

Conditions Studied

Interventions

  • PROCEDURE Care Management

Study Locations (1)

Massachusetts

  • South Cove Community Health Center - Boston

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2003-07
Est. Completion 2008-06
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT00227929 record still lists

NCT00227929 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Care Management is the first listed.

NCT00227929 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00227929 about?

NCT00227929 is a clinical study titled "Culturally Sensitive Collaborative Treatment for Depressed Chinese Americans". This study will evaluate the effectiveness of culturally sensitive treatment versus regular care in treating depressed Chinese Americans.

What is the current status of trial NCT00227929?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2003-07. Estimated completion is 2008-06.

What conditions does trial NCT00227929 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00227929?

The interventions under investigation include: Care Management (PROCEDURE).

Who is sponsoring clinical trial NCT00227929?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00227929 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00227929's enrollment target sits among peer trials

120 292nd of 679 higher than 379 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00227929, the US trial registry maintained by the National Library of Medicine. NCT00227929 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.